L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 4.83 NOK -3.78%
Market Cap: 329.7m NOK

Intrinsic Value

The intrinsic value of one LYTIX stock under the Base Case scenario is hidden NOK. Compared to the current market price of 4.83 NOK, Lytix Biopharma AS is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

LYTIX Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Lytix Biopharma AS

LYTIX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for LYTIX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LYTIX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Lytix Biopharma AS
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Lytix Biopharma AS

Current Assets 53.4m
Cash & Short-Term Investments 43.5m
Receivables 9.9m
Non-Current Assets 2.9m
PP&E 2.9m
Efficiency

Free Cash Flow Analysis
Lytix Biopharma AS

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Lytix Biopharma AS

Revenue
10.8m NOK
Operating Expenses
-93.5m NOK
Operating Income
-82.8m NOK
Other Expenses
1.9m NOK
Net Income
-80.9m NOK
Fundamental Scores

LYTIX Profitability Score
Profitability Due Diligence

Lytix Biopharma AS's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Lytix Biopharma AS's profitability score is hidden . The higher the profitability score, the more profitable the company is.

LYTIX Solvency Score
Solvency Due Diligence

Lytix Biopharma AS's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
hidden
Solvency
Score

Lytix Biopharma AS's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LYTIX Price Targets Summary
Lytix Biopharma AS

Wall Street analysts forecast LYTIX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LYTIX is 14.28 NOK with a low forecast of 14.14 NOK and a high forecast of 14.7 NOK.

Lowest
Price Target
14.14 NOK
193% Upside
Average
Price Target
14.28 NOK
196% Upside
Highest
Price Target
14.7 NOK
204% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Lytix Biopharma AS
does not pay dividends
Shareholder Yield

Current shareholder yield for LYTIX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN
What is the Intrinsic Value of one LYTIX stock?

The intrinsic value of one LYTIX stock under the Base Case scenario is hidden NOK.

Is LYTIX stock undervalued or overvalued?

Compared to the current market price of 4.83 NOK, Lytix Biopharma AS is hidden .

Back to Top